Search research articles
Contact Us
Filters
Showing results (11-20 of 121) with videos related to
Page
of 13
Sort By:
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Prognostic and treatment-predictive factors-is there a difference?
J Adolfsson, G Steineck
Mutagenesis
|
January 21, 2000
p53 intron 7 polymorphisms in urinary bladder cancer patients and controls. Stockholm Bladder Cancer Group
P Berggren, K Hemminki, G Steineck
European Journal of Cancer (Oxford, England : 1990)
|
January 3, 2003
Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
K Hemminki, Y Jiang, G Steineck
Lakartidningen
|
February 2, 1994
[Treatment of bladder cancer with cytostatic agents]
G Steineck, H Wijkström, G Borghede
Lakartidningen
|
December 24, 1986
[Nausea after cisplatin administration can be prevented with antiemetic treatment]
R Ohlsson, G Steineck, C Peterson
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
March 9, 2010
Emesis and gastrointestinal problems during radiotherapy: a comparison of performance of daily activities between patients experiencing nausea and patients free from nausea
A Enblom, G Steineck, S Börjeson
Electrophoresis
|
August 12, 2000
A rapid fluorescence based multiplex polymerase chain reaction--single-strand conformation polymorphism method for p53 mutation detection
P Berggren, G Steineck, K Hemminki
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1990
Colorectal cancer in Sweden. A descriptive epidemiologic study
M Gerhardsson, G Steineck, S E Norell
American Journal of Clinical Oncology
|
October 11, 1992
Conservative management of localized prostatic cancer
W F Whitmore, J Adolfsson, G Steineck
Cancer
|
August 15, 1997
Prostate carcinoma and long term survival
J Adolfsson, L E Rutqvist, G Steineck
Page
of 13
Search research articles
Search
Showing results (11-20 of 121) with videos related to
Sort By:
Page
of 13
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Prognostic and treatment-predictive factors-is there a difference?
J Adolfsson, G Steineck
Mutagenesis
|
January 21, 2000
p53 intron 7 polymorphisms in urinary bladder cancer patients and controls. Stockholm Bladder Cancer Group
P Berggren, K Hemminki, G Steineck
European Journal of Cancer (Oxford, England : 1990)
|
January 3, 2003
Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
K Hemminki, Y Jiang, G Steineck
Lakartidningen
|
February 2, 1994
[Treatment of bladder cancer with cytostatic agents]
G Steineck, H Wijkström, G Borghede
Lakartidningen
|
December 24, 1986
[Nausea after cisplatin administration can be prevented with antiemetic treatment]
R Ohlsson, G Steineck, C Peterson
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
March 9, 2010
Emesis and gastrointestinal problems during radiotherapy: a comparison of performance of daily activities between patients experiencing nausea and patients free from nausea
A Enblom, G Steineck, S Börjeson
Electrophoresis
|
August 12, 2000
A rapid fluorescence based multiplex polymerase chain reaction--single-strand conformation polymorphism method for p53 mutation detection
P Berggren, G Steineck, K Hemminki
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1990
Colorectal cancer in Sweden. A descriptive epidemiologic study
M Gerhardsson, G Steineck, S E Norell
American Journal of Clinical Oncology
|
October 11, 1992
Conservative management of localized prostatic cancer
W F Whitmore, J Adolfsson, G Steineck
Cancer
|
August 15, 1997
Prostate carcinoma and long term survival
J Adolfsson, L E Rutqvist, G Steineck
Page
of 13